315 related articles for article (PubMed ID: 26305912)
1. Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood.
Lanuti P; Rotta G; Almici C; Avvisati G; Budillon A; Doretto P; Malara N; Marini M; Neva A; Simeone P; Di Gennaro E; Leone A; Falda A; Tozzoli R; Gregorj C; Di Cerbo M; Trunzo V; Mollace V; Marchisio M; Miscia S
Cytometry A; 2016 Mar; 89(3):259-70. PubMed ID: 26305912
[TBL] [Abstract][Full Text] [Related]
2. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
[TBL] [Abstract][Full Text] [Related]
3. Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources.
Tura O; Barclay GR; Roddie H; Davies J; Turner ML
J Transl Med; 2007 Jul; 5():37. PubMed ID: 17640360
[TBL] [Abstract][Full Text] [Related]
4. Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of circulating endothelial progenitor cells in peripheral blood.
Smythe J; Fox A; Fisher N; Frith E; Harris AL; Watt SM
Tissue Eng Part C Methods; 2008 Mar; 14(1):59-67. PubMed ID: 18454646
[TBL] [Abstract][Full Text] [Related]
5. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
[TBL] [Abstract][Full Text] [Related]
6. Large platelets but not putative endothelial progenitor cells are associated with low strut coverage after drug-eluting stent implantation.
Nührenberg TG; Zhao M; Stratz C; Amann M; Valina CM; Gick M; Trenk D; Binder H; Büttner HJ; Neumann FJ
Int J Cardiol; 2015 Nov; 199():358-65. PubMed ID: 26247791
[TBL] [Abstract][Full Text] [Related]
7. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
8. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul.
Dome P; Teleki Z; Rihmer Z; Peter L; Dobos J; Kenessey I; Tovari J; Timar J; Paku S; Kovacs G; Dome B
Mol Psychiatry; 2009 May; 14(5):523-31. PubMed ID: 18180758
[TBL] [Abstract][Full Text] [Related]
9. Optimized flow cytometric analysis of endothelial progenitor cells in peripheral blood.
Rustemeyer P; Wittkowski W; Jurk K; Koller A
J Immunoassay Immunochem; 2006; 27(1):77-88. PubMed ID: 16450870
[TBL] [Abstract][Full Text] [Related]
10. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.
Dome B; Timar J; Dobos J; Meszaros L; Raso E; Paku S; Kenessey I; Ostoros G; Magyar M; Ladanyi A; Bogos K; Tovari J
Cancer Res; 2006 Jul; 66(14):7341-7. PubMed ID: 16849585
[TBL] [Abstract][Full Text] [Related]
11. Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol.
Huizer K; Mustafa DAM; Spelt JC; Kros JM; Sacchetti A
PLoS One; 2017; 12(9):e0184895. PubMed ID: 28910385
[TBL] [Abstract][Full Text] [Related]
12. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes.
Jung C; Rafnsson A; Shemyakin A; Böhm F; Pernow J
Int J Cardiol; 2010 Sep; 143(3):368-72. PubMed ID: 19398138
[TBL] [Abstract][Full Text] [Related]
13. Jagged-1 Signaling in the Bone Marrow Microenvironment Promotes Endothelial Progenitor Cell Expansion and Commitment of CD133+ Human Cord Blood Cells for Postnatal Vasculogenesis.
Ishige-Wada M; Kwon SM; Eguchi M; Hozumi K; Iwaguro H; Matsumoto T; Fukuda N; Mugishima H; Masuda H; Asahara T
PLoS One; 2016; 11(11):e0166660. PubMed ID: 27846321
[TBL] [Abstract][Full Text] [Related]
14. Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men.
Esposito K; Ciotola M; Maiorino MI; Giugliano F; Autorino R; De Sio M; Jannini E; Lenzi A; Giugliano D
J Sex Med; 2009 Jan; 6(1):107-14. PubMed ID: 19170841
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cells.
Zubair AC; Malik S; Paulsen A; Ishikawa M; McCoy C; Adams PX; Amrani D; Costa M
Cytotherapy; 2010 Apr; 12(2):178-89. PubMed ID: 20078384
[TBL] [Abstract][Full Text] [Related]
16. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors.
Case J; Mead LE; Bessler WK; Prater D; White HA; Saadatzadeh MR; Bhavsar JR; Yoder MC; Haneline LS; Ingram DA
Exp Hematol; 2007 Jul; 35(7):1109-18. PubMed ID: 17588480
[TBL] [Abstract][Full Text] [Related]
17. Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.
Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
J Hematother Stem Cell Res; 2001 Dec; 10(6):807-14. PubMed ID: 11798507
[TBL] [Abstract][Full Text] [Related]
18. Three specific antigens to isolate endothelial progenitor cells from human liposuction material.
Hager G; Holnthoner W; Wolbank S; Husa AM; Godthardt K; Redl H; Gabriel C
Cytotherapy; 2013 Nov; 15(11):1426-35. PubMed ID: 24094492
[TBL] [Abstract][Full Text] [Related]
19. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
[TBL] [Abstract][Full Text] [Related]
20. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
